A Kodak board member's impeccable timing

For Kodak, July 29 looked like a miracle. The beleaguered film company's stock, which started the week at $2.10, was soaring — at one point reaching $60. The market was reacting to the news that the Trump administration was loaning the company $765 million to enter the generic pharmaceutical business.

Read →